164 related articles for article (PubMed ID: 35831141)
1. Expression of lncRNA APF in Peripheral Blood of Patients with Acute Myocardial Infarction Caused by Coronary Heart Disease and its Clinical Significance.
Zeng H; Hu F; Duan Y; Li H; Wang Y
Int Heart J; 2022 Jul; 63(4):742-748. PubMed ID: 35831141
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA muscleblind like splicing regulator 1 antisense RNA 1 (LncRNA MBNL1-AS1) promotes the progression of acute myocardial infarction by regulating the microRNA-132-3p/SRY-related high-mobility-group box 4 (SOX4) axis.
Liu W; Lin W; Yu L
Bioengineered; 2022 Jan; 13(1):1424-1435. PubMed ID: 34978261
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of miR-492 in peripheral blood of acute myocardial infarction.
Guo LL; Chen HH; Qu FC; Lu QH
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9041-9045. PubMed ID: 32964994
[TBL] [Abstract][Full Text] [Related]
4. Implication of peripheral blood miRNA-124 in predicting acute myocardial infarction.
Guo ML; Guo LL; Weng YQ
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):1054-1059. PubMed ID: 28338188
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNAs H19, MALAT1 and MIAT as potential novel biomarkers for diagnosis of acute myocardial infarction.
Wang XM; Li XM; Song N; Zhai H; Gao XM; Yang YN
Biomed Pharmacother; 2019 Oct; 118():109208. PubMed ID: 31302423
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNA-21 is a potential diagnostic biomarker of acute myocardial infarction.
Zhang Y; Liu YJ; Liu T; Zhang H; Yang SJ
Eur Rev Med Pharmacol Sci; 2016; 20(2):323-9. PubMed ID: 26875904
[TBL] [Abstract][Full Text] [Related]
7. Circulating miR-208b: A Potentially Sensitive and Reliable Biomarker for the Diagnosis and Prognosis of Acute Myocardial Infarction.
Liu X; Yuan L; Chen F; Zhang L; Chen X; Yang C; Han Z
Clin Lab; 2017 Jan; 63(1):101-109. PubMed ID: 28164501
[TBL] [Abstract][Full Text] [Related]
8. LncRNA NEAT1/miR-211/IL-10 Axis Regulates Inflammation of Peripheral Blood Mononuclear Cells in Acute Myocardial Infarction.
Hou MN; Zong GJ; Sun Y; Jiang JJ; Ding J
Int Heart J; 2024; 65(3):498-505. PubMed ID: 38825494
[TBL] [Abstract][Full Text] [Related]
9. Weak diagnostic performance of troponin, creatine kinase and creatine kinase-MB to diagnose or exclude myocardial infarction after successful resuscitation.
Kruse JM; Enghard P; Schröder T; Hasper D; Kühnle Y; Jörres A; Storm C
Int J Cardiol; 2014 May; 173(2):216-21. PubMed ID: 24636545
[TBL] [Abstract][Full Text] [Related]
10. Clinical Value of Combined Detection of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction.
Fan J; Ma J; Xia N; Sun L; Li B; Liu H
Clin Lab; 2017 Mar; 63(3):427-433. PubMed ID: 28271683
[TBL] [Abstract][Full Text] [Related]
11. [Research on expression of miRNA-21 in the peripheral blood of coronary heart disease and its clinical significance].
Yang SJ; Zhang Y; Liu Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Mar; 31(2):127-31. PubMed ID: 26248417
[TBL] [Abstract][Full Text] [Related]
12. Circulating miR-130 is a potential bio signature for early prognosis of acute myocardial infarction.
Pan X; He Y; Chen Z; Yan G; Ma G
J Thorac Dis; 2020 Dec; 12(12):7320-7325. PubMed ID: 33447421
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation on usage of serum troponin-I, CK-MBmass and myoglobin measurements in diagnosing acute myocardial infarction].
Wang L; Wu Y; Li L
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):239-41, 245. PubMed ID: 12515148
[TBL] [Abstract][Full Text] [Related]
14. Extracellular ubiquitin levels are increased in coronary heart disease and associated with the severity of the disease.
Ji Y; Yao J; Zhao Y; Zhai J; Weng Z; He Y
Scand J Clin Lab Invest; 2020 May; 80(3):256-264. PubMed ID: 32077763
[No Abstract] [Full Text] [Related]
15. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.
Okamoto F; Sohmiya K; Ohkaru Y; Kawamura K; Asayama K; Kimura H; Nishimura S; Ishii H; Sunahara N; Tanaka T
Clin Chem Lab Med; 2000 Mar; 38(3):231-8. PubMed ID: 10905760
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.
Wu AH; Smith A; Christenson RH; Murakami MM; Apple FS
Clin Chim Acta; 2004 Aug; 346(2):211-9. PubMed ID: 15256323
[TBL] [Abstract][Full Text] [Related]
17. [Quantitative analysis of serum troponin I and myoglobin in patients with acute myocardial infarction].
Xiao HG; Huang ZH; Liu HX; Lin YP
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):550-1. PubMed ID: 15897132
[TBL] [Abstract][Full Text] [Related]
18. Postmortem cardiac troponin I and creatine kinase MB levels in the blood and pericardial fluid as markers of myocardial damage in medicolegal autopsy.
Zhu BL; Ishikawa T; Michiue T; Li DR; Zhao D; Bessho Y; Kamikodai Y; Tsuda K; Okazaki S; Maeda H
Leg Med (Tokyo); 2007 Sep; 9(5):241-50. PubMed ID: 17459758
[TBL] [Abstract][Full Text] [Related]
19. Cardiac markers in the early hours of acute myocardial infarction: clinical performance of creatine kinase, creatine kinase MB isoenzyme (activity and mass concentration), creatine kinase MM and MB subform ratios, myoglobin and cardiac troponin T.
Hetland O; Dickstein K
Scand J Clin Lab Invest; 1996 Dec; 56(8):701-13. PubMed ID: 9034351
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of cardiac troponin I in patients with acute myocardial infarction].
Ikeda J; Zenimoto M; Kita M; Mori M
Rinsho Byori; 2002 Oct; 50(10):982-6. PubMed ID: 12451679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
